Distinct interethnic differences in immunoglobulin G class/subclass and immunoglobulin M antibody responses to malaria antigens but not in immunoglobulin G responses to nonmalarial antigens in sympatric tribes living in West Africa.
The well-established relative resistance to malaria observed in the Fulani as compared with other sympatric tribes in West Africa has been attributed to their higher levels of serum immunoglobulin (Ig) G antibodies to malarial antigens. In this study, we confirm and extend the previous findings by analyses of the levels of IgM, IgG and IgG subclasses of anti-malarial antibodies in asymptomatic individuals of different sympatric tribes in Burkina Faso (Fulani/Mossi) and Mali (Fulani/Dogon). The Fulani showed significantly higher median concentrations of anti-malarial IgG and IgM antibodies than the sympatric tribes at both locations. Although the overall subclass pattern of antibodies did not differ between the tribes, with IgG1 and IgG3 as dominant, the Fulani showed consistently significantly higher levels of these subclasses as compared with those of the non-Fulani individuals. No significant differences were seen in the levels of total IgG between the tribes, but the Fulani showed significantly higher levels of total IgM than their neighbours in both countries. While the antibody levels to some nonmalarial antigens showed the same pattern of differences seen for antibody levels to malaria antigens, no significant such differences were seen with antibodies to other nonmalarial antigens. In conclusion, our results show that the Fulani in two different countries show higher levels of anti-malarial antibodies than sympatric tribes, and this appears not to be a reflection of a general hyper-reactivity in the Fulani.
Bolad
A
A
Department of Immunology, Wenner-Gren Institute, Stockholm University, S-10691 Stockholm, Sweden.
Farouk
S E
SE
Israelsson
E
E
Dolo
A
A
Doumbo
O K
OK
Nebié
I
I
Maiga
B
B
Kouriba
B
B
Luoni
G
G
Sirima
B S
BS
Modiano
D
D
Berzins
K
K
Troye-Blomberg
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000913:Antibodies, Protozoan / Q000096:biosynthesis / Q000097:blood*; D000941:Antigens / Q000276:immunology* / Q000494:pharmacology; D000942:Antigens, Bacterial / Q000097:blood / Q000276:immunology / Q000494:pharmacology; D000953:Antigens, Protozoan / Q000276:immunology / Q000494:pharmacology; D000956:Antigens, Viral / Q000097:blood / Q000276:immunology / Q000494:pharmacology; D002050:Burkina Faso; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000097:blood*; D007075:Immunoglobulin M / Q000096:biosynthesis / Q000097:blood*; D016778:Malaria, Falciparum / Q000097:blood / Q000208:ethnology* / Q000276:immunology* / Q000469:parasitology; D008302:Mali; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000276:immunology*; D044382:Population Groups; D012424:Rural Population
D000913:Antibodies, Protozoan; D000941:Antigens; D000942:Antigens, Bacterial; D000953:Antigens, Protozoan; D000956:Antigens, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M